149 related articles for article (PubMed ID: 23650612)
1. The cytoplasmic tail of heparin-binding EGF-like growth factor regulates bidirectional intracellular trafficking between the plasma membrane and ER.
Hieda M; Koizumi M; Higashi C; Tachibana T; Taguchi T; Higashiyama S
FEBS Open Bio; 2012; 2():339-44. PubMed ID: 23650612
[TBL] [Abstract][Full Text] [Related]
2. Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membrane.
Hieda M; Isokane M; Koizumi M; Higashi C; Tachibana T; Shudou M; Taguchi T; Hieda Y; Higashiyama S
J Cell Biol; 2008 Feb; 180(4):763-9. PubMed ID: 18299347
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic domain phosphorylation of heparin-binding EGF-like growth factor.
Wang X; Mizushima H; Adachi S; Ohishi M; Iwamoto R; Mekada E
Cell Struct Funct; 2006; 31(1):15-27. PubMed ID: 16557002
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells.
Ozeki K; Tanida S; Morimoto C; Inoue Y; Mizoshita T; Tsukamoto H; Shimura T; Kataoka H; Kamiya T; Nishiwaki E; Ishiguro H; Higashiyama S; Joh T
PLoS One; 2013; 8(2):e56770. PubMed ID: 23451083
[TBL] [Abstract][Full Text] [Related]
5. Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer.
Shimura T; Kataoka H; Ogasawara N; Kubota E; Sasaki M; Tanida S; Joh T
Clin Cancer Res; 2008 Jun; 14(12):3956-65. PubMed ID: 18559618
[TBL] [Abstract][Full Text] [Related]
6. Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the C-terminal fragment in the cell cycle.
Toki F; Nanba D; Matsuura N; Higashiyama S
J Cell Physiol; 2005 Mar; 202(3):839-48. PubMed ID: 15389565
[TBL] [Abstract][Full Text] [Related]
7. Extracellular calcium influx stimulates metalloproteinase cleavage and secretion of heparin-binding EGF-like growth factor independently of protein kinase C.
Dethlefsen SM; Raab G; Moses MA; Adam RM; Klagsbrun M; Freeman MR
J Cell Biochem; 1998 May; 69(2):143-53. PubMed ID: 9548562
[TBL] [Abstract][Full Text] [Related]
8. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading.
Gechtman Z; Alonso JL; Raab G; Ingber DE; Klagsbrun M
J Biol Chem; 1999 Oct; 274(40):28828-35. PubMed ID: 10497257
[TBL] [Abstract][Full Text] [Related]
9. The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascades.
Takenobu H; Yamazaki A; Hirata M; Umata T; Mekada E
J Biol Chem; 2003 May; 278(19):17255-62. PubMed ID: 12611888
[TBL] [Abstract][Full Text] [Related]
10. Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.
Shimura T; Yoshida M; Fukuda S; Ebi M; Hirata Y; Mizoshita T; Tanida S; Kataoka H; Kamiya T; Higashiyama S; Joh T
BMC Cancer; 2012 May; 12():205. PubMed ID: 22646534
[TBL] [Abstract][Full Text] [Related]
11. TGFβ induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells.
Ebi M; Kataoka H; Shimura T; Kubota E; Hirata Y; Mizushima T; Mizoshita T; Tanaka M; Mabuchi M; Tsukamoto H; Tanida S; Kamiya T; Higashiyama S; Joh T
Biochem Biophys Res Commun; 2010 Nov; 402(3):449-54. PubMed ID: 20934403
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.
Goishi K; Higashiyama S; Klagsbrun M; Nakano N; Umata T; Ishikawa M; Mekada E; Taniguchi N
Mol Biol Cell; 1995 Aug; 6(8):967-80. PubMed ID: 7579712
[TBL] [Abstract][Full Text] [Related]
13. Roles of charged amino acid residues in the cytoplasmic domain of proHB-EGF.
Nanba D; Toki F; Higashiyama S
Biochem Biophys Res Commun; 2004 Jul; 320(2):376-82. PubMed ID: 15219838
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism for activation of heparin-binding EGF-like growth factor induced by stimuli].
Umata T
J UOEH; 2004 Mar; 26(1):85-97. PubMed ID: 15038074
[TBL] [Abstract][Full Text] [Related]
15. Induction of collecting duct morphogenesis in vitro by heparin-binding epidermal growth factor-like growth factor.
Takemura T; Hino S; Kuwajima H; Yanagida H; Okada M; Nagata M; Sasaki S; Barasch J; Harris RC; Yoshioka K
J Am Soc Nephrol; 2001 May; 12(5):964-972. PubMed ID: 11316855
[TBL] [Abstract][Full Text] [Related]
16. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
17. Dual intracellular signaling by proteolytic cleavage of membrane-anchored heparin-binding EGF-like growth factor.
Nanba D; Higashiyama S
Cytokine Growth Factor Rev; 2004 Feb; 15(1):13-9. PubMed ID: 14746810
[TBL] [Abstract][Full Text] [Related]
18. BAG-1 is a novel cytoplasmic binding partner of the membrane form of heparin-binding EGF-like growth factor: a unique role for proHB-EGF in cell survival regulation.
Lin J; Hutchinson L; Gaston SM; Raab G; Freeman MR
J Biol Chem; 2001 Aug; 276(32):30127-32. PubMed ID: 11340068
[TBL] [Abstract][Full Text] [Related]
19. Insufficiency of pro-heparin-binding epidermal growth factor-like growth factor shedding enhances hypoxic cell death in H9c2 cardiomyoblasts via the activation of caspase-3 and c-Jun N-terminal kinase.
Uetani T; Nakayama H; Okayama H; Okura T; Higaki J; Inoue H; Higashiyama S
J Biol Chem; 2009 May; 284(18):12399-409. PubMed ID: 19193634
[TBL] [Abstract][Full Text] [Related]
20. Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme.
Nishi E; Hiraoka Y; Yoshida K; Okawa K; Kita T
J Biol Chem; 2006 Oct; 281(41):31164-72. PubMed ID: 16923819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
